SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 1842.66 millions for the June 2022 quarter. The mentioned figure indicates a growth of about 43.22% as compared to Rs. 1286.57 millions during the year-ago period.The Net Profit of the company registered a slight decline of -12.21% to Rs. 113.90  millions from Rs. 129.74 millions.OP of the company witnessed a marginal growth to 281.59 millions from 254.76 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1842.66 1286.57 43.22 1842.66 1286.57 43.22 6765.66 5548.72 21.93
Other Income 27.07 8.04 236.69 27.07 8.04 236.69 104.63 76.71 36.40
PBIDT 281.59 254.76 10.53 281.59 254.76 10.53 1645.47 1191.77 38.07
Interest 39.30 15.38 155.53 39.30 15.38 155.53 90.90 47.90 89.77
PBDT 242.29 239.38 1.22 242.29 239.38 1.22 1554.57 1143.87 35.90
Depreciation 89.42 65.22 37.11 89.42 65.22 37.11 344.16 257.15 33.84
PBT 152.87 174.16 -12.22 152.87 174.16 -12.22 1210.41 886.72 36.50
TAX 38.97 44.42 -12.27 38.97 44.42 -12.27 312.23 239.79 30.21
Deferred Tax 29.11 0.96 2932.29 29.11 0.96 2932.29 26.10 -6.12 -526.47
PAT 113.90 129.74 -12.21 113.90 129.74 -12.21 898.18 646.93 38.84
Equity 195.98 195.88 0.05 195.98 195.88 0.05 195.98 195.88 0.05
PBIDTM(%) 15.28 19.80 -22.83 15.28 19.80 -22.83 24.32 21.48 13.23

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×